A detailed history of Price T Rowe Associates Inc transactions in Lifevantage Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,700 shares of LFVN stock, worth $132,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,700
Previous 20,700 -0.0%
Holding current value
$132,894
Previous $125,000 0.8%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$4.22 - $7.51 $21,944 - $39,052
-5,200 Reduced 20.08%
20,700 $134,000
Q2 2021

Aug 16, 2021

SELL
$6.9 - $9.59 $7,369 - $10,242
-1,068 Reduced 3.96%
25,900 $190,000
Q1 2021

May 17, 2021

BUY
$8.58 - $10.21 $36,894 - $43,903
4,300 Added 18.97%
26,968 $252,000
Q4 2020

Feb 16, 2021

BUY
$9.32 - $13.4 $211,265 - $303,751
22,668 New
22,668 $211,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $80.6M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.